Expert Interview

This project has been flagged by a community member as inappropriate due to reason below.*

Expert Interview

Slingshot members are talking to an expert! The topic is:

Discussing the current treatment landscape for retinal diseases with a prescriber of Eylea and Vabysmo.

Ticker(s): REGN, RHHBY

Who's the expert?

Institution: University of Minnesota

Vitreoreitnal surgeon and Associate Professor of Ophthalmology at University of Minnesota
Manages over 100+ patients with wet-AMD
Research Interest and Peer reviewed publications in imaging technology for vitreoretinal care and Macular degeneration.

Interview Goal

This call will feature a discussion on the current standard of care and the use of Eylea from Regeneron and Vabysmo from Roche for the treatment of retinal diseases.

Are You Interested In These Questions?

Yes! Sign me up for FREE
so I can learn more Yes.
LOGIN!

Click Here to Access
This Project

Slingshot Insights Explained

JOIN FOR FREE TODAY

Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.

Reason

Click Here to Access
This Project

*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.